tbuckley/cabot-search huggingface dataset:
Frailty-Based Outcomes with Bispecific Antibodies in Older Patients with Multiple Myeloma
Authors: Nadine Abdallah, Matthew Rees, Supriya Gupta, Mohammed Elhaj, Radhika Bansal, Terri Menser, Gavin Schaeferle, Joselle Cook, Taxiarchis Kourelis, Rahma M Warsame, Wilson I. Gonsalves, Prashant Kapoor, Francis Buadi, Suzanne R Hayman, David Dingli, Morie A. Gertz, Yi Lin, Shaji Kumar
Journal: Blood (2024)
First in-Class JAK2 Inhibitor OB756 Therapy for Patients with Polycythemia Vera : A Phase 2, Open-Label, Multicenter Study
Authors: Jian Huang, Bingbing Wen, Tiejun Gong, Hu Zhou, Lihong Shou, Qingchi Liu, Feng Zhang, Cuicui WU, Wei Yang, Lidong Zhao, Lili Chen, Jian Lu, Yile Zhou, Yi Zhang, Jie Jin
Journal: Blood (2024)
A Phase III Randomized Trial for Frail Newly Diagnosed Multiple Myeloma Patients Comparing Bortezomib- Lenalidomide-Dexamethasone (VRd-Lite followed by Len maintenance) with Daratumumab-Lenalidomide- Dexamethasone (DRd followed by Len+/- Dara Maintenance): SWOG S2209
Authors: Sikander Ailawadhi, Antje Hoering, J Christine Ye, Brea Lipe, Thomas R. Chauncey, Krisstina Gowin, David Calverley, Sarah A. Holstein, Erica L. Campagnaro, Adam Rosenthal, Jack Aiello, Saad Z. Usmani, Vincent Rajkumar, Robert Z. Orlowski
Journal: Blood (2024)
Selinexor Combined with Tislelizumab in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (R/R ENKTL): Preliminary Results of Arm C, from a Multicenter, Single-Arm, Phase I/II Study, Touch
Authors: Rong Tao, Chuanxu Liu, Yan Gao, Yang Yu, Zhi Guo, Jun Zhao, Huiqiang Huang
Journal: Blood (2024)
Iron Deficiency in Immune Thrombocytopenia: Are We Doing Enough?
Authors: Analy Mora, Fausto A Rios-Olais, Anna Olive-Madrigal, Alvaro Edelmann-Alonso, Vania Yael Aguirre Muñoz, Juan Luis Ontiveros-Austria, Ivan Arnaud-Borboa, Roberta Demichelis
Journal: Blood (2024)
Italian Real-World Experience of Gilteritinib Monotherapy in Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Preliminary Results
Authors: Rosa Greco, Silvia Imbergamo, Elisabetta Pierdomenico, Barbara Di Camillo, Cristina Papayannidis, Elisabetta Todisco, Erika Borlenghi, Nicola Fracchiolla, Claudia Basilico, Monica Fumagalli, Patrizia Zappasodi, Mauro Turrini, Anna Candoni, Monia Lunghi, Maurizio Musso, Calogero Vetro, Fabio Guolo, Donato Mannina, Albana Lico, Anna Maria Scattolin, Gianpaolo Nadali, Monica Crugnola, Sara Galimberti, Francesco Marchesi, Elisabetta Metafuni, Tommaso Caravita di Toritto, Clara Minotti, Pellegrino Musto, Valentina Mancini, Marta Riva, Lorenzo Rizzo, Giovanni Grillo, Roberto Cairoli
Journal: Blood (2024)
Clonal Dissection of MDS and Secondary AML Resolves Shared Splicing Neoantigens and Mechanistic Underpinnings of Hypomethylating Agent Therapeutic Response
Authors: Xuan Zhang, Guangyuan Li, Anna Oliverio, Jennifer VanOudenhove, Amy E. DeZern, Gabriel Ghiaur, Stephanie Halene, H. Leighton Grimes, Nathan Salomonis
Journal: Blood (2024)
Clonal Hematopoiesis of Indeterminate Potential Is Associated with Decreased Inflammatory Toxicity and Increased Late Cytopenia in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy
Authors: Brittany Knick Ragon, Manisha Bhutani, Barry Paul, Yifan Pang, Cindy Varga, Srinivasa Reddy Sanikommu, Bei Hu, Ryan Jacobs, Tamara K Moyo, Shebli Atrash, Christopher J Ferreri, Steven I. Park, David M Foureau, Nilanjan Ghosh, Peter M. Voorhees, Ariel Bell, Phillip Holmes-Snowden, Olga Better, Nury M. Steuerwald, Wei Sha, Lawrence J. Druhan, Michael R. Grunwald
Journal: Blood (2024)
Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Patients with Newly Diagnosed Chronic Myeloid Leukemia Aged 50 - 60 Years: A “Campus CML” Study
Authors: Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Atelda Romano, Federica Sorà, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Francesco Cavazzini, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Marco Santoro, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Michele Pizzuti, Alessandra Iurlo, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood (2024)
Trends and Disparities in Idiopathic Thrombocytopenic Purpura-Related Mortality in the United States: A Retrospective Study over Two Decades
Authors: Moazzam Shahzad, Shahzaib Ahmed, Eeman Ahmad, Umar Akram, Haider Ashfaq, Hamza Ashraf, Sudeepthi Bandikatla, Qamar Iqbal, Turab Mohammad, Atif Butt, Muhammad Umair Mushtaq, Michael V. Jaglal
Journal: Blood (2024)
Impact of Patient and Donor Factors on Successful Hematopoietic Stem Cell Transplantation for Acute T-Cell Leukemia/Lymphoma Patients in an Underserved Minority Population
Authors: John Yan, Parth Patel, Simran Arjani, Eliot A Rapoport, Brittany Moavero, Jhannine Verceles, Angela Czavar, Emma Cordover, Julie Nguyen, Kira Gritsman, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Nishi Shah, Ridhi Gupta, Marina Konopleva, Amit Verma, Eric J. Feldman, Dennis L Cooper, Mendel Goldfinger, R. Alejandro Sica, Lauren Shapiro
Journal: Blood (2024)
Evaluating Minimal Residual Disease Negativity As a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials
Authors: Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Anastasios Ntanasis-Stathopoulos, Panagiotis Malandrakis, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou
Journal: Blood (2024)
Primary Hematopoietic Cells of Vexas Patients Are Highly Sensitive to Treatment with TAK-243 and Pevonedistat
Authors: Marie Demmerle, Alessa Klär, Alexander Streuer, Vladimir Riabov, Eva Altrock, Felicitas Rapp, Ann-Christin Belzer, Teresa Klink, Meret Hahn, Franziska Hofmann, Verena Nowak, Nadine Weimer, Julia Oblaender, Iris Palme, Melda Göl, Ali Darwich, Mohammed Abba, Georgia Metzgeroth, Wolf-Karsten Hofmann, Daniel Nowak, Nanni Schmitt
Journal: Blood (2024)
A Deep-Learning Pipeline for Diagnosis of Myelodysplastic Syndromes/Neoplasms Using Bone Marrow Smears
Authors: Palak Dave, Jordan Rai, Ling Zhang, Mohammad Omar Hussaini, Mary Ellen Walker, Nancy Gillis, Mikkael A. Sekeres, Amy E. DeZern, Eric Padron, Rami S. Komrokji, Issam El Naqa
Journal: Blood (2024)
Classification of NK-Large Granular Lymphocytic Leukemia By CD56 Expression
Authors: Yuxi Li, Jingjing Yuan, Rui Cui, Ying Yu, Yanshan Huang, Yuting Yan, Jingwen Sun, Tingyu Wang, Rui Lyu, Xiong Wenjie, Qi Wang, Wei LIU, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Fengkui Zhang, Huijun Wang, Lugui Qiu, Shuhua Yi
Journal: Blood (2024)
Real-World Experience of Patients and Caregivers with Early-Line Treatment of Chronic Myeloid Leukemia in the US: A Retrospective 2-Year Social-Media Listening Analysis
Authors: Gaurav Vadnerkar, Joan Clements, Mel Mann, Vainavika Reddy Gaddam, Chaitali Nag, Shiva Padhi, David Wei, Marcello Azolino, Kejal Jadhav, Daisy Yang, Andrea Damon, Islam Sadek
Journal: Blood (2024)
Frailty Syndrome Is Associated with Increased Endothelial Activation and Post-Transplant Complications in Allo-HCT Patients
Authors: Maria Queralt Salas, Julia Martinez-Sanchez, Raquel Salinas González, Blanca de Moner, ANA Belen MORENO Castaño, Silvia Escribano-Serrat, Alex Ramos, Carla Mestre, Cristina Padilla, Laia Guardia, Filipe Pinto, Paola Charry, Joan Cid, Miquel Lozano, Enric Cascos, Jordi Esteve, Sara Laxe, Concepción Closa, Enric Carreras, Maria Suarez-Lledo, Laura Rosiñol Dachs, Francesc Fernández-Avilés, Montserrat Rovira, Maria Carmen Martinez Munoz, Maribel Diaz-Ricart
Journal: Blood (2024)
Randomised Controlled Trial of High Dose Dexamethasone and Methylprednisolone in Immune Thrombocytopenia (HDMI Trial)
Authors: Kundan Mishra, Saqib Rashid, Kanwal Jeet Singh, Preeti Tripathi, Revanth Boddu, Rajat Bahl, Rajeev Kumar, Rajan Kapoor, Venkatesan Somasundaram, Suman Kumar
Journal: Blood (2024)
Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study
Authors: Mazyar Shadman, Nancy L. Bartlett, Matthew Matasar, Stephen J. Schuster, Sarit E. Assouline, Laurie H. Sehn, John Kuruvilla, Pratyush Giri, Chan Y. Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta Nastoupil, Michael C. Wei, Shen Yin, Connie Y. Ma, Samuel Tracy, Antonia Kwan, Elicia Penuel, L. Elizabeth Budde
Journal: Blood (2024)
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST): A Multi-Center Randomized Double-Blinded Placebo-Controlled Phase IIa Trial
Authors: Benjamin H Mullish, Andrew J Innes, Rohma Ghani, Shian Anim-Burton, Lee Webber, Graham Wheeler, Nicholas A Johnson, Lauren Roberts, Frances J Davies, Julian R Marchesi, Jiri Pavlu
Journal: Blood (2024)
Molecular Predictors of Disease Progression to Myelofibrosis (MF) in Patients (Pts) with Polycythemia Vera (PV) Enrolled in Reveal
Authors: Stephen T. Oh, Jeffrey I. Zwicker, Kamal Patel, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, Justine Carl, J.E. Hamer-Maansson, Valkal Bhatt, Evan M. Braunstein, Michael R. Grunwald
Journal: Blood (2024)
Impact of Non-<i>ABL1</i> Mutations on Outcomes in Patients with Chronic Myeloid Leukemia
Authors: Akriti G. Jain, Joy Nakitandwe, Krishna Desai, Genevieve M Crane, David S. Bosler, Jill O'Brien, Moaath K. Mustafa Ali, John C. Molina, Sophia Balderman, Anjali S. Advani, Hetty E. Carraway, Aaron T. Gerds, Abhay Singh, Matt Kalaycio, Sudipto Mukherjee
Journal: Blood (2024)
Low Regimen Therapeutic Strategies to Mitigate TET2 Mutant Clonal Hematopoiesis
Authors: Dongxu Jiang, Daniel J Vail, Yahan Zhang, Raziullah Khan, Anand Tiwari, Simon Schlanger, Kunho Chung, Cassandra Gilmour, Xiaorong Gu, Yvonne Parker, J. Joseph Melenhorst, Daniel Lindner, Jaroslaw Maciejewski, Babal K. Jha
Journal: Blood (2024)
Improved Outcomes for Primary Refractory Classical Hodgkin Lymphoma: A Retrospective Analysis
Authors: Alayna M. Santarosa, Nivetha Ganesan, Tiffany Chang, Kelly Hannigan, Ellie Casper, Gunjan L. Shah, Alexander P. Boardman, Philip Caron, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Ariel Krivisky, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Heiko Schoder, Raphael E. Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood (2024)
Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized Trial (TE-ITP study)
Authors: Yunfei Chen, Ting Sun, Da Gao, Wei Wang, ZePing Zhou, Guangxun Gao, Yi Wang, Hu Zhou, Yanping Song, Yinghui Lai, Zhenyu Yan, Jinsong Yan, Jie Bai, Lei Zhang
Journal: Blood (2024)
Pharmacodynamic Activity of Recombinant ADAMTS13 Versus Plasma-Based Therapies in Congenital Thrombotic Thrombocytopenic Purpura: Interim Results of a Phase 3 Randomized, Controlled, Open-Label Study
Authors: Munjal Patel, Björn Mellgård, Luying Pan, Linda T. Wang, Shan Xiao, Parth Patwari
Journal: Blood (2024)
Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia
Authors: Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Linn, Gopila Gupta, Emilia Scalzulli, Tomoiku Takaku, Hiroshi Ureshino, Shinya Kimura, Sung-Eun Lee, Dragana Milojkovic, Andrew J Innes, Simone Claudiani, Valentín García Gutiérrez, Jiri Mayer, Peter E. Westerweel, Dennis Dong Hwan Kim
Journal: Blood (2024)
Combinatorial Effect of Chronic Alcohol Drinking and Age Perpetuates Myeloid-Biased Hematopoiesis Via Hematopoietic Stem Cell Senescence
Authors: Ridzky A. A. Yuda, Valerie Kellet, Haruna B. Choijilsuren, Zewen Ha, Fan Yang, Moonjung Jung
Journal: Blood (2024)
Multimodal Single Cell Analysis Reveals Hematopoietic Changes across the Human Lifespan
Authors: Tomoya Isobe, Mariana Quiroga Londoño, Nicole Mende, Emily Stephenson, Deena Iskander, Simone Webb, Issac Goh, Vijay Shanmugiah, Rebecca Hannah, Anindita Roy, Irene Roberts, Elisa Laurenti, Muzlifah Haniffa, Nicola K. Wilson, Berthold Gottgens
Journal: Blood (2024)
Comparison of Two Conditioning Regimens for Haploidentical Stem Cell Transplantation in Patients with Severe Aplastic Anemia
Authors: Fan Lin, Lanping Xu, Zhengli Xu, Ting-Ting Han, Yun He, Yuan-Yuan Zhang, Yi-Fei Cheng, Xiao-Dong Mo, Jingzhi Wang, Yu Wang, Xiaohui Zhang, Xiaojun Huang
Journal: Blood (2024)
Targeting Inflammation in Tet2 Mutant Clonal Hematopoiesis Via Inhibition of Brd4 Demonstrates Activity in Both Murine and Human Models
Authors: Alexander R. Marr, Madeline Halpin, Dominique L. Corbin, Britten K. Gordon, Samon Benrashid, Ethan C. Whipp, Jean Truxall, Olivia Cahn, Bethany L. Mundy-Bosse, Julia Cooper, Marina Beltrami Moreira, James S. Blachly, Uma Borate, Jennifer A. Woyach, Rosa Lapalombella, Nicole R. Grieselhuber
Journal: Blood (2024)
APAL2020K/ITCC-101: A Phase I Trial of the Menin Inhibitor Ziftomenib in Combination with Chemotherapy in Children with Relapsed/Refractory <i>KMT2A-</i>rearranged<i>, NUP98-</i>rearranged<i>, or NPM1-</i>mutant Acute Leukemias
Authors: Elisabeth Salzer, Janine Stutterheim, Branko Cuglievan, Blake E. Tomkinson, Mollie Leoni, Harm Van Tinteren, Alwin D.R. Huitema, Marieke Willemse, Gwen L Nichols, Francisco Bautista, Sarah K. Tasian, Todd M Cooper, Christian Zwaan
Journal: Blood (2024)
Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL
Authors: Lichao Liu, Ruihao Huang, Yongxian Hu, Sanfang Tu, Na Wang, Hai Yi, Qiuying Gao, Jian Zhou, Xiaoqi Wang, Cheng Zhang, Xi Zhang
Journal: Blood (2024)
Real-World Treatment Patterns, Resource Utilization, and Cost of Care in Medicare Beneficiaries Newly Diagnosed with Acute Myeloid Leukemia and Treated with Venetoclax-Based Regimens
Authors: Joshua A. Roth, Paul G D'Amico, Alexander Russell-Smith, Simon Purcell, Elizabeth Donckels, Joseph C. Cappelleri, Jia Ma, Allison Petrilla, Jerry Kagan, Anthony Yu
Journal: Blood (2024)
CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma
Authors: Eva Castellano, Almudena García-Ortiz, Laura Ugalde, Elena Maroto Martin, Jessica Encinas Mayoral, Raquel Oliva, Laura Garcia-Garcia, Irene Peña, Noemi Álvarez, Gonzalo Carreño, Rosa Ayala, Laura Cordoba, Alejandra Leivas, Guillermo Suñe, Beatriz Martin Antonio, Rafael Alonso Fernandez, Maria Teresa Cedena Romero, Joaquín Martínez-Lopez, Paula Rio, Antonio Valeri
Journal: Blood (2024)
A Study on the Effect of Luspatercept on Regulatory T Cells and Myeloid Derived Suppressor Cells in Low Risk Myelodysplastic Syndrome with Ring Sideroblasts
Authors: Stefania Leone, Francesco Grimaldi, Mara Memoli, Flavia Carriero, Giulia Scalia, Annamaria Vincenzi, Giuseppe Cerciello, Fabrizio Pane, Alessandra Picardi, Giuseppe Terrazzano, Giuseppina Ruggiero, Valentina Rubino
Journal: Blood (2024)
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two Institutes
Authors: Cindy Varga, Myra Robinson, Vikas Gupta, Craig C. Hofmeister, Ajay K. Nooka, Jonathan L. Kaufman, Madhav V. Dhodapkar, Sagar Lonial, Shanice Borden, Christopher Ferreri, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Nisha S. Joseph
Journal: Blood (2024)
Clinical Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with Advanced Therapies in the United States
Authors: David J Kuter, Imene Gouia, Matias Cordoba, Brad Ward, Siddhi Umarje, Kalyani Hawaldar, Aurelien Carlicchi, Natalia Petruski-Ivleva
Journal: Blood (2024)
VISTA As a Mediator of Immune Suppression in AML Initiated By <i>DNMT3A</i> and <i>NPM1</i> mutations
Authors: Tiankai Yin, Michael H. Kramer, Michael Bern, Nichole Helton, Daniel George, Mieke Hoock, Sai Mukund Ramakrishnan, Christopher A Miller, Timothy J Ley
Journal: Blood (2024)
A Phase I/II Study of AZD0305, a Novel Antibody-Drug Conjugate (ADC) Targeting GPRC5D, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Sueh-Li Lim, Bradley Augustson, Hira S Mian, Edward A. Stadtmauer, Shinsuke Iida, Michael Slade, Saswati Hazra, Kamal Chamoun, Patricia Cheung, Jamal Saeh, Nina Shah, Amrita Y Krishnan
Journal: Blood (2024)
Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation
Authors: Michael Spencer Chapman, Emily Mitchell, Kenichi Yoshida, Nicholas Williams, Margarete A. Fabre, Anna Maria Ranzoni, Philip S. Robinson, Lori Kregar, C. Matthias Wilk, Steffen Boettcher, Krishnaa Mahbubani, Kourosh Saeb-Parsy, Stanley Ng, George S Vassiliou, Kate Gowers, Sam Janes, Matt Hoare, Anthony R Green, Ana Cvejic, Markus G. Manz, Elisa Laurenti, Inigo Martincorena, Michael Stratton, Jyoti Nangalia, Tim H.H. Coorens, Peter Campbell
Journal: Blood (2024)
Highly Effective Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Helps Overcome Social Determinants of Health in Medically Underserved Populations
Authors: Bradley Rockwell, Nitya Dhanaraj, Mark Forsberg, Swati Goel, David Levitz, Ridhi Gupta, Lauren Shapiro, Noah Kornblum, Eric J. Feldman
Journal: Blood (2024)
The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients
Authors: Thomas Ernst, Jenny Rinke, Philipp le Coutre, Martina Crysandt, Tim H. H. Brummendorf, Andreas Burchert, Fabian Lang, Susanne Saussele, Markus Pfirrmann, Thomas Lang, Christian Fabisch, Andreas Hochhaus
Journal: Blood (2024)
Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
Authors: Hee Jeong Cho, Myung-Won Lee, Yunji Lee, Jungmin Lee, Jae Hoon Lee, Hyun-Seok Uhm, Jong Heon Jung, Ho-Young Yhim, Dok Hyun Yoon, Hyungwoo Cho, Sung-Soo Yoon, Ja Min Byun, Young Rok Do, Hyo Jung Kim, Ji Hyun Lee, Sung-Nam Lim, Hye Jin Kang, Ho Sup Lee, Yundeok Kim, Hee jeong Lee, Sang Min Lee, Joon Ho Moon, Kihyun Kim
Journal: Blood (2024)
Demographics, Characteristics, Survival and Outcomes in Older, Untreated, Acute Myeloid Leukemia Patients with <i>NPM1</i> Mutations or <i>KMT2A</i> rearrangements from the Beat AML Master Clinical Trial
Authors: Uma Borate, Rina Li Welkie, Ying Huang, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Yazan F Madanat, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, William Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor J. Kovacsovics, Michael W. Deininger, Joshua F Zeidner, Rebecca Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K Curran, Kristin L Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Gullen Marcus, Leonard Rosenberg, Brian J. Druker, Ross L Levine, Amy Burd, Ashley Owen Yocum, Alice Mims, John C. Byrd
Journal: Blood (2024)
High Molecular Risk Mutations (HMR) Drive Progression of <i>CALR</i>-mutated Myeloproliferative Neoplasm (MPN)
Authors: Resham Mawalkar, Hua-Ling Tsai, Terra Marie M Jouaneh, Shivam Patel, Christopher Gocke, Eitan Halper-Stromberg, Rena R. Xian, K. C. Rappazzo, Evan M. Braunstein, Alison R. Moliterno, Tania Jain
Journal: Blood (2024)
What Is the Prognostic Relevance of Responses Less Than a CR(Sub-CR) to Initial AML Treatment?
Authors: Akhil Rajendra, Elliot Smith, Eshetu Atenafu, Aniket Bankar, Steven M. Chan, Marta Beata Davidson, Vikas Gupta, Mark D. Minden, Maria Agustina Perusini, Guillaume Richard-Carpentier, Aaron D Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Dawn C. Maze
Journal: Blood (2024)
Distinct Effects of Cigarette Smoke and e-Cigarette Aerosols on Inflammation and Stem Cell Proliferation in Clonal Hematopoiesis
Authors: Jeanette YC Sullivan, Jane H Chen, Xin (Helen) Huang, Jianhong C Heidmann, Gajalakshmi Ramanathan, Nneamaka Iwobi, Nicole Sparks, David Herman, Michael Kleinman, Angela G. Fleischman
Journal: Blood (2024)
Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study
Authors: Ka-Won Kang, Yumin Choi, Hyung-Jun Lim, Kunye Kwak, Yoon Seok Choi, Yong Park, Byung Soo Kim, Kwang-Sig Lee, Ki Hoon Ahn
Journal: Blood (2024)
Phase 1 Study of TT-01488, a Novel, Non-Covalent, Reversible BTK Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies
Authors: Yufu Li, Wei Xu, Caixia Li, Pengcheng He, Wei Yang, Xiangmin Tong, Ying Wang, Hongchan Zhang, Caixia Sun, Zejuan Sheng, Jean Fan, Jianyong Li
Journal: Blood (2024)
Outcomes of Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia Given Blinatumomab As Last Consolidation Treatment before Allogeneic Hematopoietic Cell Transplantation
Authors: Mattia Algeri, Michele Massa, Daria Pagliara, Valentina Bertaina, Federica Galaverna, Ilaria Pili, Giuseppina Li Pira, Roberto Carta, Francesco Quagliarella, Rita Maria Pinto, Chiara Rosignoli, Barbarella Lucarelli, Maria Giuseppina Cefalo, Emilia Boccieri, Francesca Benini, Francesca Del Bufalo, Marco Becilli, Pietro Merli, Gerhard Zugmaier, Franco Locatelli
Journal: Blood (2024)
Resistance to FLT3 Inhibitors in FLT3-Mutated AML Is Associated with CD45RA+CD200- leukemic Cells and Can be Overcome By Combination with SMAC Mimetics
Authors: Nona Struyf, Henrik Gezelius, Anders Lundmark, Chiara Barizza, Hidde Ploeger, Lucía Rico Pizarro, Mattias Vesterlund, Georgios Mermelekas, Albin Osterroos, Anna Bohlin, Sofia Bengtzén, Kerstin Hamberg Levedahl, Rozbeh Jafari, Lukas M Orre, Janne Lehtiö, Päivi Östling, Brinton Seashore-Ludlow, Jessica Nordlund, Soren Lehmann, Olli Kallioniemi, Tom Erkers
Journal: Blood (2024)
A Phase 1 Study of NKX019, an Allogeneic Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy in Patients with Systemic Lupus Erythematosus
Authors: Anca Askanase, Leila Khalili, Cornell Chang, Alison Blaus, Phung Gip, Elaine Karis, David Shook
Journal: Blood (2024)
MRD By Flow Cytometry and FDG-PET/CT for the Post-Induction Response Assessment in Patients with Multiple Myeloma Treated in the Phase 3 GMMG HD7 Study
Authors: Marina Hajiyianni, Christos Sachpekidis, Annette Kopp-Schneider, Elias Karl Mai, Sandra Sauer, Ekaterina Menis, Michael Hundemer, Niels Weinhold, Jens Hillengass, Marc-Steffen Raab, Antonia Dimitrakopoulou-Strauss, Hartmut Goldschmidt
Journal: Blood (2024)
Quinine-Hemin Compound As an Anti-Inflammatory Therapy in Sickle Cell Disease
Authors: Kai Dou, Rikang Wang, Weili Bao, Yunfeng Liu, Shan Su, Avital Mendelson, Cheryl Lobo, Patricia Shi, Xiuli An, Karina Yazdanbakhsh, Hui Zhong
Journal: Blood (2024)
Survival and Treatment Response in CTCL Can be Predicted Using Volumetric Lymph Node Size and Dynamic Changes in Lymph Node Size and Skin Score
Authors: Alexander Kaminsky, Lauren M. Fahmy, Zaid Bilgrami, Hye Ryung Yang, Volkan Beylergil, Mengxi Zhou, Antonio T. Fojo, Susan E. Bates, Lawrence Schwartz, Larisa J Geskin
Journal: Blood (2024)